How do you approach adjuvant radiation treatment planning for R1/R2, node-negative NSCLC?

There are no guidelines for this.

Dose: I would go to 54-60 Gy for positive margins (lower for focal, higher for diffuse)/microscopic disease and a bit higher for gross disease, 60-66 Gy (lower if there is not a "mass", higher if there is visible gross disease).

If KPS supports, I would want to cons...